Search results
Oct 26, 2023 · Erythema multiforme can affect people of any age, with children representing 20 percent of cases. However, it most commonly occurs in young adults between 20 and 30 years old.
- Adrienne Stinson
Erythema multiforme is an immune-mediated, typically self-limiting, mucocutaneous condition characterised by ‘target’ lesions as seen in the images below. Treatment is often not needed as episodes are typically self-limiting with no ongoing complications.
Erythema multiforme usually gets better on its own in 2 to 4 weeks. Sometimes, you may need: moisturisers or steroid creams to speed up recovery and help ease symptoms like itching. treatment for the infection that's causing it, such as antiviral medicine for a virus.
This leaflet has been written to help you understand more about erythema multiforme. It tells you what it is, what causes it, what can be done about it, and where you can find out more about it. What is erythema multiforme? Erythema multiforme (EM) is a hypersensitivity reaction which tends to develop suddenly.
Erythema multiforme (air-uh-THEE-muh mul-teh-FOR-mee) starts with pink or red blotches. They grow over a few days into round spots that look like targets with red, pink, and pale rings. Often, the rash starts on the arms, hands, legs, and feet, then appears on the face, neck, diaper area, and body.
Erythema multiforme is a rare condition that can affect anyone, but it’s most common among children, young adults and people under the age of 40. How does erythema multiforme affect my body? Erythema multiforme usually causes a painful or uncomfortable rash on your skin.
People also ask
How common is erythema multiforme?
What is erythema multiforme (EM)?
What if I download a photo of a erythema multiforme (EM)?
What if my child has erythema multiforme?
Nov 16, 2021 · Erythema multiforme (EM) is a hypersensitivity reaction usually triggered by infections, most commonly herpes simplex virus. Clinically, EM is characterised by macular, papular or urticated lesions, as well as the classical 'target lesions' distributed preferentially on the distal extremities .
